โมลนูพิราเวียร์ (Thai Wikipedia)

Analysis of information sources in references of the Wikipedia article "โมลนูพิราเวียร์" in Thai language version.

refsWebsite

Global rank Thai rank

4^th place

7^th place

2^nd place

4^th place

5,225^th place

7,482^nd place

1,248^th place

1,350^th place

857^th place

309^th place

615^th place

1,105^th place

low place

234^th place

348^th place

acs.org

Halford, Bethany. "An emerging antiviral takes aim at COVID-19". สืบค้นเมื่อ 1 August 2020.

Court, Emma (31 July 2020). "Merck pushes ahead on COVID-19 treatment, vaccines". สืบค้นเมื่อ 31 July 2020.

Toots M, Yoon JJ, Cox RM, Hart M, Sticher ZM, Makhsous N, และคณะ (October 2019). "Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia". Science Translational Medicine. 11 (515): eaax5866. doi:10.1126/scitranslmed.aax5866. PMC 6848974. PMID 31645453.
Toots M, Yoon JJ, Hart M, Natchus MG, Painter GR, Plemper RK (April 2020). "Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model". Translational Research. 218: 16–28. doi:10.1016/j.trsl.2019.12.002. PMID 31945316. PMC 7568909.
Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, และคณะ (April 2020). "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice". Science Translational Medicine. 12 (541): eabb5883. doi:10.1126/scitranslmed.abb5883. PMC 7164393. PMID 32253226.
Robert M. Cox; Josef D. Wolf; Richard K. Plemper (2020-12-03). "Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets". Nature Microbiology. Vol. 6 no. 11–18. doi:10.1038/s41564-020-00835-2.

Toots M, Yoon JJ, Cox RM, Hart M, Sticher ZM, Makhsous N, และคณะ (October 2019). "Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia". Science Translational Medicine. 11 (515): eaax5866. doi:10.1126/scitranslmed.aax5866. PMC 6848974. PMID 31645453.
Toots M, Yoon JJ, Hart M, Natchus MG, Painter GR, Plemper RK (April 2020). "Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model". Translational Research. 218: 16–28. doi:10.1016/j.trsl.2019.12.002. PMID 31945316. PMC 7568909.
Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, และคณะ (April 2020). "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice". Science Translational Medicine. 12 (541): eabb5883. doi:10.1126/scitranslmed.abb5883. PMC 7164393. PMID 32253226.

Toots M, Yoon JJ, Cox RM, Hart M, Sticher ZM, Makhsous N, และคณะ (October 2019). "Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia". Science Translational Medicine. 11 (515): eaax5866. doi:10.1126/scitranslmed.aax5866. PMC 6848974. PMID 31645453.
Toots M, Yoon JJ, Hart M, Natchus MG, Painter GR, Plemper RK (April 2020). "Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model". Translational Research. 218: 16–28. doi:10.1016/j.trsl.2019.12.002. PMID 31945316. PMC 7568909.
Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, และคณะ (April 2020). "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice". Science Translational Medicine. 12 (541): eabb5883. doi:10.1126/scitranslmed.abb5883. PMC 7164393. PMID 32253226.

Cohen, Jon; Piller, Charles (13 May 2020). "Emails offer look into whistleblower charges of cronyism behind potential COVID-19 drug". Science. สืบค้นเมื่อ 1 August 2020.